Evidence map›Paper›PMID 26739894›Full record

ArticleAmerican journal of physiology. Renal physiology2016

Muc1 enhances the β-catenin protective pathway during ischemia-reperfusion injury.

Mohammad M Al-Bataineh, Carol L Kinlough, Paul A Poland, Núria M Pastor-Soler, Timothy A Sutton, Henry E Mang, Sheldon I Bastacky, Sandra J Gendler, Cathy S Madsen, Sucha Singh and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of physiology. Renal physiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 30 citations in OpenAlex.

  1. Expression and distribution of MUC1 in the developing and adult kidney.American journal of physiology. Renal physiology · 2025
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Novel roles for mucin 1 in the kidney.Current opinion in nephrology and hypertension · 2017
    Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Mohammad M Al-BatainehRenal-Electrolyte Division, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania;
Carol L KinloughRenal-Electrolyte Division, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania;
Paul A PolandRenal-Electrolyte Division, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania;
Núria M Pastor-SolerDivision of Nephrology and Hypertension, Department of Medicine, University of Southern California/UKRO Kidney Research Center, Keck School of Medicine of the University of Southern California, Los Angeles, California;
Timothy A SuttonDivision of Nephrology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana;
Henry E MangDivision of Nephrology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana;
Sheldon I BastackyDivision of Anatomic Pathology, Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania;
Sandra J GendlerDepartment of Immunology and Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine and Comprehensive Cancer Center, Mayo Clinic in Arizona, Scottsdale, Arizona.
Cathy S MadsenDivision of Anatomic Pathology, Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania;
Sucha SinghDivision of Experimental Pathology, Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania;
Satdarshan P MongaDivision of Experimental Pathology, Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania;
Rebecca P HugheyRenal-Electrolyte Division, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; and Department of Cell Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania hugheyr@pitt.edu.
University of Pittsburgh · USIndiana University – Purdue University Indianapolis · USIndiana University School of MedicineMayo Clinic in Arizona · USUniversity of Southern California · US

Funding

Single Nephron and MetabolomicsP30DK079307 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KLEYMAN, THOMAS R · 2008 to 2022
$13.4M
Functional Study of Mucin MUC1R01CA064389 · NCI · MAYO CLINIC COLL OF MED, MAYO CLINIC AZ · PI GENDLER, SANDRA J · 1994 to 2014
$4.9M
Role of Platelet derived growth factor receptor-a in Liver Patho-biologyR01DK095498 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MONGA, SATDARSHAN SINGH · 2013 to 2017
$1.7M
Mechanisms of Kinase-dependent Regulation of the V-ATPase in KidneyR01DK084184 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI PASTOR-SOLER, NURIA M. · 2009 to 2013
$1.5M
Modifying kidney injury through p53 signaling.R01DK099345 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI DAGHER, PIERRE C, SUTTON, TIMOTHY ALAN · 2014 to 2017
$1.4M
Targeting beta-catenin in liver pathology: Novel Interactions, Novel ParadigmsR01DK100287 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MONGA, SATDARSHAN SINGH · 2013 to 2016
$1.3M
Role of Muc1 in Acute Kidney InjuryR56DK107632 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HUGHEY, REBECCA P, JACKSON, EDWIN KERRY · 2015 to 2015
$100k
NCI NIH HHS CA-64389NIDDK NIH HHS DK-079307NIDDK NIH HHS DK-084184NIDDK NIH HHS DK-095498NIDDK NIH HHS DK-099345NIDDK NIH HHS DK-100287NIDDK NIH HHS DK-62277NIDDK NIH HHS P30 DK079307NIDDK NIH HHS P30-DK-079307NIDDK NIH HHS R01 DK084184NIDDK NIH HHS R01 DK099345NIDDK NIH HHS R01 DK100287NIDDK NIH HHS R56 DK107632
6 · The paper itself

Abstract

The hypoxia-inducible factor (HIF)-1 and β-catenin protective pathways represent the two most significant cellular responses that are activated in response to acute kidney injury. We previously reported that murine mucin (Muc)1 protects kidney function and morphology in a mouse model of ischemia-reperfusion injury (IRI) by stabilizing HIF-1α, enhancing HIF-1 downstream signaling, and thereby preventing metabolic stress (Pastor-Soler et al. Muc1 is protective during kidney ischemia-reperfusion injury. Am J Physiol Renal Physiol 308: F1452-F1462, 2015). We asked if Muc1 regulates the β-catenin protective pathway during IRI as 1) β-catenin nuclear targeting is MUC1 dependent in cultured human cells, 2) β-catenin is found in coimmunoprecipitates with human MUC1 in extracts of both cultured cells and tissues, and 3) MUC1 prevents β-catenin phosphorylation by glycogen synthase kinase (GSK)3β and thereby β-catenin degradation. Using the same mouse model of IRI, we found that levels of active GSK3β were significantly lower in kidneys of control mice compared with Muc1 knockout (KO) mice. Consequently, β-catenin was significantly upregulated at 24 and 72 h of recovery and appeared in the nuclear fraction at 72 h in control mouse kidneys. Both β-catenin induction and nuclear targeting were absent in Muc1 KO mice. We also found downstream induction of β-catenin prosurvival factors (activated Akt, survivin, transcription factor T cell factor 4 (TCF4), and its downstream target cyclin D1) and repression of proapoptotic factors (p53, active Bax, and cleaved caspase-3) in control mouse kidneys that were absent or aberrant in kidneys of Muc1 KO mice. Altogether, the data clearly indicate that Muc1 protection during acute kidney injury proceeds by enhancing both the HIF-1 and β-catenin protective pathways.

Indexed as

AnimalsApoptosisBasic Helix-Loop-Helix Leucine Zipper Transcription Factorsbcl-2-Associated X Proteinbeta CateninCyclin D1Hypoxia-Inducible Factor 1Inhibitor of Apoptosis ProteinsMaleMice, Inbred C57BLMice, KnockoutMucin-1Proto-Oncogene Proteins c-aktReperfusion InjuryRepressor ProteinsSurvivinBasic Helix-Loop-Helix Leucine Zipper Transcription Factorsbcl-2-Associated X Proteinbeta CateninBirc5 protein, mouseCTNNB1 protein, mouseCyclin D1Hypoxia-Inducible Factor 1Inhibitor of Apoptosis Proteinsmuc1 protein, mouseMucin-1Proto-Oncogene Proteins c-aktRepressor ProteinsSurvivinTcf4 protein, mouseTranscription Factor 4Tumor Suppressor Protein p53acute kidney injuryischemiamucin 1β-catenin

Identifiers

PMID26739894
PMCPMC4796271
OpenAlexW2227575066

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.